Clinical trial
Matrix Metalloproteinases and Diabetic Nephropathy
NCT00067886 · Arkansas Children's Hospital Research Institute, Other · Completed
Key facts
| NCT number | NCT00067886 |
|---|---|
| Title | Matrix Metalloproteinases and Diabetic Nephropathy |
| Official title | Matrix Metalloproteinases and Diabetic Nephropathy |
| Lead sponsor | Arkansas Children's Hospital Research Institute, Other |
| Collaborators | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Diabetes Mellitus, Type 1, Diabetic Nephropathy |
| Enrollment | 330 |
| Start date | Mar 1, 2003 |
| Primary completion | Dec 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Sep 1, 2003 |
| Last update posted | Apr 13, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: